Control-IQ™ technology is the latest remote software update for your Tandem t:slim X2 insulin pump.
Trying to keep your blood sugar in range can be stressful and time consuming. The Control-IQ advanced hybrid closed-loop technology on the t:slim X2 insulin pump can make it easier by predicting and helping to prevent lows AND highs.
Control-IQ uses Dexcom G6 continuous glucose monitoring (CGM) values to predict glucose levels 30 minutes ahead and automatically adjusts insulin to help increase time in range (3.9 – 10 mmol/L).* Dexcom G6 is the first real-time, integrated continuous glucose monitoring (CGM) system requiring ZERO fingerpricks for calibration or mealtime dosing.^
Designed to help lighten the burden of diabetes management and offer more time in a healthy glucose level range, Control-IQ aims at making it easier to live with T1 diabetes.
Tandem t:slim X2 Insulin Pump is funded for eligible patients through Pharmac. Click here to view Pharmac Funding Criteria for insulin pumps
The Control-IQ™ software update is FREE** if you have an in-warranty Tandem t:slim X2 pump AND have subscribed to our Dexcom 360 Programme for Dexcom G6 Continuous Glucose Monitoring (CGM) at the time of the launch.
You will need to first talk to your Diabetes team about Control-IQ™ to make sure it’s right for you. There is still plenty of time to book an appointment with your healthcare professional and to renew your pump’s Special Authority and to get started on Dexcom G6.
Stay tuned to this page for upcoming announcements. Click here for more information on Dexcom G6.
Designed to help prevent highs or lows and to increase time in range (3.9 – 10 mmol/L)*, Control-IQ technology predicts glucose values 30 minutes ahead.
Automatic Insulin Adjustments
Control-IQ™ technology automatically adjusts insulin levels based on Dexcom G6 CGM readings.§
For added protection, Control-IQ technology can also deliver automatic correction boluses (up to one an hour) to help prevent hyperglycaemia.†
Control-IQ technology includes optional settings for Sleep and Exercise that adjust range of treatment values for more targeted control.
Control-IQ technology predicts glucose values 30 minutes ahead, based on Dexcom G6 CGM readings, and can decrease or stop basal insulin delivery to help prevent lows, or increase basal insulin delivery to help avoid highs.
Control-IQ Status Icon: Icons display on the pump screen to visually indicate when insulin delivery is increasing, decreasing, or stopped. Please refer to the table for a breakdown of status icons.
The Control-IQ remote update will be available for FREE** to all existing Tandem t:slim X2 users who have an IN-WARRANTY pump and are signed up to our Dexcom 360 Programme at the time of launch (in May 2021).‡
If you get a new pump after the launch date and are signed up to the Dexcom 360 Programme, you will get a 50% discount on the cost of Control-IQ software and pay only $250 + GST. ‡
Please refer to the table for full pricing information. (Price per pump upgrade. Upgrade linked to pump Serial Number and not transferable.)
|-||Tandem user is on the Dexcom 360 Programme||Tandem user is not on the Dexcom 360 Programme|
|Tandem pump was purchased/dispensed prior to launch date and is still IN-WARRANTY||FREE ‡||$500 ‡|
|Tandem pump was purchased/dispensed post launch date||$250 ‡||$500 ‡|
Further announcements to come as we approach the date of the launch.
For more information about Dexcom G6, please click here.
*As measured by CGM.
^If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
**Dexcom G6 CGM is required to use the Tandem t:slim X2 insulin pump with Control-IQ Technology.
§Dexcom CGM sold separately. Transmitter can only be paired with one medical device (either a Dexcom receiver or t:slim X2 insulin pump) and one consumer device (phone or tablet) at the same time.
†If glucose values are predicted to be above 10,0 mmol/L, Control-IQ technology calculates a correction bolus using the Personal Profile settings and a target of 6,1 mmol/L and delivers 60% of that value. An Automatic Correction Bolus will not occur within 60 minutes of a bolus that has been delivered or cancelled.
‡ Pricing current as of 10 March 2021 and subject to change without notice. Price per single pump update.
Tandem software updates are only available for in-warranty pumps. Upgrade linked to pump Serial Number and not transferable.
1. Brown SA, Kovatchev BP, Raghinaru D, et al. Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes. N Eng J Med. 2019;381(18):1701-1717.
2. Brown, S. Clinical acceptance of the artificial pancreas: Glycemia outcomes from a 6-month multicenter RCT. 2019 ADA 79th Scientific Sessions, San Francisco, CA.
RESPONSIBLE USE OF CONTROL-IQ TECHNOLOGY
Control-IQ™ technology does not prevent all high and low blood glucose events, and is not a substitute for meal boluses and active self-management of diabetes. Control-IQ technology will not be able to predict sensor glucose values and adjust insulin dosing if a patient’s CGM is not working properly or is unable to communicate with their pump. Patients should be instructed to always pay attention to their symptoms and blood glucose levels and treat accordingly.
IMPORTANT SAFETY INFORMATION
The t:slim X2 insulin pump and the t:slim X2 insulin pump with Control-IQ technology are intended for single patient use. The t:slim X2 pump and the t:slim X2 pump with Control-IQ technology are indicated for use with NovoRapid or Humalog U-100 insulin. t:slim X2 insulin pump: The t:slim X2 pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices. The t:slim X2 pump is indicated for use in individuals six years of age and greater. t:slim X2 insulin pump with Control-IQ technology: The t:slim X2 pump with Control-IQ technology is intended for use with a compatible continuous glucose monitor (CGM, sold separately) and the t:slim X2 pump to automatically increase, decrease, and suspend delivery of basal insulin based on CGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. The t:slim X2 pump with Control-IQ technology is intended for persons six years of age and greater.
WARNING: The t:slim X2 pump with Control-IQ technology should not be used by anyone under the age of six years old. It should also not be used in patients who require less than 10 units of insulin per day or who weigh less than 25 kilograms.
The t:slim X2 pump with Control-IQ technology is not indicated for use in pregnant women, people on dialysis, or critically ill patients. Do not use the t:slim X2 pump with Control-IQ technology if using hydroxyurea. Users of the t:slim X2 pump and the t:slim X2 pump with Control-IQ technology must: use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognise all functions of the pump, including alerts, alarms, and reminders. All Tandem Diabetes Care pumps, transmitters, and sensors must be removed before MRI, CT, or diathermy treatment. Visit tandemdiabetes.com/safetyinfo for additional important safety information.
Now you can get all the latest news and updates of our products, events and resources right into your inbox.
We are always happy to help, send us a message or enquiry